Bone Biologics Corporation
BBLG
$0.55
-$0.01-1.07%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -39.28% | 64.93% | 60.43% | 69.61% | 184.74% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -10.80% | -12.59% | -12.69% | -28.41% | -27.62% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 25.17% | 24.83% | -19.02% | -42.88% | -67.86% |
| Total Current Assets | -36.64% | 57.47% | 50.10% | 56.20% | 119.26% |
|
|
|||||
| Total Current Assets | -36.64% | 57.47% | 50.10% | 56.20% | 119.26% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -36.64% | 57.47% | 50.10% | 56.20% | 119.26% |
|
|
|||||
| Total Accounts Payable | 26.70% | 24.66% | 12.04% | 75.22% | 74.08% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -79.17% | -87.88% | -85.11% | -98.56% | -95.44% |
| Total Other Current Liabilities | -79.17% | -87.88% | -85.11% | -98.56% | -95.44% |
| Total Current Liabilities | 26.08% | 23.17% | 10.83% | 22.28% | 42.74% |
|
|
|||||
| Total Current Liabilities | 26.08% | 23.17% | 10.83% | 22.28% | 42.74% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 26.08% | 23.17% | 10.83% | 22.28% | 42.74% |
|
|
|||||
| Common Stock & APIC | 0.24% | 5.19% | 5.65% | 7.07% | 9.25% |
| Retained Earnings | -3.33% | -3.32% | -3.66% | -4.73% | -5.11% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -40.50% | 60.43% | 54.36% | 58.65% | 126.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -40.50% | 60.43% | 54.36% | 58.65% | 126.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -40.50% | 60.43% | 54.36% | 58.65% | 126.75% |
|
|
|||||